Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2011 Oct;63(10):2848-50.
doi: 10.1002/art.30505.

Biosimilars: the debate continues

Robert A Colbert  1 , Bruce N Cronstein
Affiliations
Editorial

Biosimilars: the debate continues

Robert A Colbert et al. Arthritis Rheum. 2011 Oct.
No abstract available

PubMed Disclaimer

References

    1. Carey K. Biosimilars encircle Rituxan, US debates innovator exclusivity. Nat Biotech. 2011;29:177. - PubMed
    1. Jelkmann W. Biosimilar epoetins and other “follow-on” biologics: Update on the European experiences. Amer J Hematol. 2010;85:771. - PubMed

    1. Department of Health and Human Services, Food and Drug Administration, Docket No. FDA-2010-N-0477

    1. Mullard A. Hearing shines spotlight on biosimilar controversies. Nat Rev Drug Disc. 2010;9:905. - PubMed
    1. Similarity trials. Nat Biotech. 2011;29:1. - PubMed

Publication types